The New Yorker writes about Merck and Vioxx
“While that kind of weighing of risk and benefit may be medically rational, in the legal arena itÂ’s poison.” (via PointofLaw.com)
ADVERTISEMENT
More in Uncategorized
Past Week
-
Your doctor saved your life but won’t return your call [PODCAST]
-
Why bipolar II is not just a milder version of bipolar I
-
Opt-out states and physician-led anesthesia care explained
-
How medical misinformation drives demand for nonscientific treatments
-
Treating adolescent opioid use disorder with buprenorphine
-
Bolus or drip? What the DOSE trial actually showed about heart failure [PODCAST]
-
Past 6 Months
-
I Googled my own name and a corporate clinic I’ve never worked at appeared [PODCAST]
-
Rethinking the role of family physicians vs. specialists
-
How corporate health care ruined the medical profession
-
Clinicians are failing at value-based care because no one taught them the system [PODCAST]
-
A humorous parody of medical specialties and the modern patient
-
When shared decision making gives way to medical paternalism
-
Recent Posts
-
Bolus or drip? What the DOSE trial actually showed about heart failure [PODCAST]
-
Accounts receivable days hide four billing problems
-
AI therapy chatbots are crossing into impersonation
-
The handwashing standard nobody finished. Until now.
-
Expanding the SOAP framework boosts health outcomes
-
How to navigate physician job loss in the first week
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
